Literature DB >> 12867583

Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.

A Crilly1, J Hamilton, C J Clark, A Jardine, R Madhok.   

Abstract

OBJECTIVES: Fibrosis, a feature of systemic sclerosis (SSc), is more severe in the diffuse compared with the limited disease variant. Interleukin 10 (IL-10) is an anti-inflammatory cytokine which reduces type 1 collagen mRNA levels in human fibroblasts. The 5' flanking region of the IL-10 gene is highly polymorphic, with three single base pair substitutions at position -1082(G/A), -819(C/T) and -592(C/A), which results in differential IL-10 production. The GCC/GCC genotype is associated with high IL-10 production while the ATA/ATA genotype with low production. We postulated that there would be a difference in IL-10 polymorphisms in patients with limited (lSSc) and diffuse (dSSc) disease.
METHODS: Patients with limited (lSSc, n = 89) or diffuse (dSSc, n = 51) disease plus controls (n = 94) were recruited. DNA was isolated from peripheral blood and polymorphisms analysed using amplification refractory mutation system (ARMS) polymerase chain reaction (PCR).
RESULTS: dSSc patients were less likely to carry the genotype indicative of high IL-10 production when compared with controls (controls vs dSSc; 29 vs 4%, chi2 = 15.7, 5 df, P = 0.005) and lSSc patients (lSSc vs dSSc; 21 vs 4%, chi2 = 17.5, 5 df, P = 0.002). There was no difference between control and lSSc patients. While there was no difference between controls and lSSc haplotypes, the GCC haplotype distribution did differ significantly between controls and dSSc patients (controls vs dSSc; 54 vs 36%, chi2 = 11.2, 2 df, P = 0.001). A significant difference was also observed between lSSc and dSSc haplotype distribution (lSSc vs dSSc; 48 vs 36%, chi2 = 13.5, 2 df, P < 0.001).
CONCLUSION: We demonstrate that IL-10 genotypes associated with high IL-10 production are under-represented in dSSc. This may have implications in the disease pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867583     DOI: 10.1093/rheumatology/keg420

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement.

Authors:  O Ates; B Müsellim; G Ongen; A Topal-Sarikaya
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

3.  Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus.

Authors:  Hildson Dornelas Angelo da Silva; Alex Paulino da Silva; Helker Albuquerque da Silva; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

Review 4.  Genetics and proteomics in scleroderma.

Authors:  Carol A Feghali-Bostwick
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 5.  Systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Jérôme Le Pavec; Marc Humbert; Luc Mouthon; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

6.  Haplotype analysis of IL-10 gene polymorphism in couples with spontaneous abortions and aborted fetuses.

Authors:  M Vidyadhari; M Sujatha; P Krupa; Pratibha Nallari; A Venkateshwari
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

7.  Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia.

Authors:  S Sowmya; K Sri Manjari; A Ramaiah; T Sunitha; P Nallari; A Jyothy; A Venkateshwari
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 8.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Heart Fail Clin       Date:  2012-07       Impact factor: 3.179

Review 9.  Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

Authors:  Gloria Salazar; Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2015-05-20       Impact factor: 2.670

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases.

Authors:  Adel Boueiz; Paul M Hassoun
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.